Orforglipron
Category: Oral GLP-1 Agonist
Non-peptide oral GLP-1 receptor agonist in development offering pill-based alternative.
Half-Life: 24 hours
Benefits
- Oral administration
- No injections needed
- Daily pill convenience
- Comparable efficacy to injectables in trials
Side Effects
- Nausea
- Vomiting
- Decreased appetite
- GI effects